Figure 2. Workflow of genomic engineering in organoids.

Before in vitro differentiation into organoids, pluripotent stem cells (ESCs and iPSCs) or multipotent somatic stem cells can be genomically modified in various ways. The resulting genomically edited organoids play critical roles in applications such as disease modeling and drug testing.